Article
Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
Antimicrobial agents and chemotherapy - 1 Nov 2004
Nahimana Aimable, Rabodonirina Meja, Bille Jacques, Francioli Patrick, Hauser Philippe M
Abstract excerpt
Most drugs used for prevention and treatment of Pneumocystis jirovecii pneumonia target enzymes involved in the biosynthesis of folic acid, i.e., dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR). Emergence of P. jirovecii drug resistance has been suggested by the association between failure of prophylaxis with sulfa drugs and mutations in DHPS. However, data on the occurrence of mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
